» Authors » Evan C Adelstein

Evan C Adelstein

Explore the profile of Evan C Adelstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 486
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adelstein E, Saba S, Jain S, Wang N
Pacing Clin Electrophysiol . 2019 Nov; 43(1):78-86. PMID: 31674681
Background: Implantable cardioverter-defibrillator (ICD) recipients who receive appropriate device therapies have limited survival, and survival benefit in chronic kidney disease (CKD) has been questioned. We examined the association between CKD...
2.
Zhang L, Steckman D, Adelstein E, Schulman-Marcus J, Loka A, Mathew R, et al.
Cardiovasc Drugs Ther . 2019 Jun; 33(4):481-488. PMID: 31165356
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance and is associated with increased risk of thromboembolism. Oral anticoagulants are effective at reducing rates of thromboembolism in patients with...
3.
Wang N, Mezu-Chukwu U, Adelstein E, Althouse A, Sharbaugh M, Jain S, et al.
Ann Noninvasive Electrocardiol . 2019 Mar; 24(4):e12641. PMID: 30919524
Background: Sex differences in clinical outcomes for left bundle branch block (LBBB)-associated idiopathic nonischemic cardiomyopathy (NICM) after cardiac resynchronization therapy (CRT) are not well described. Methods: A retrospective cohort study...
4.
Adelstein E, Althouse A, Davis L, Schwartzman D, Bazaz R, Jain S, et al.
J Cardiovasc Electrophysiol . 2018 Dec; 30(3):348-356. PMID: 30575185
Introduction: Amiodarone reduces recurrent ventricular tachyarrhythmias (VTA) but may worsen cardiovascular outcomes in heart failure (HF) patients. Cardiac resynchronization therapy (CRT) may also be antiarrhythmic. When patients with prior sustained...
5.
Wang N, Hussain A, Adelstein E, Althouse A, Sharbaugh M, Jain S, et al.
Ann Noninvasive Electrocardiol . 2018 Sep; 24(2):e12603. PMID: 30267454
Background: Baseline predictors of myocardial recovery after cardiac resynchronization therapy (CRT) in left bundle branch block (LBBB)-associated idiopathic nonischemic cardiomyopathy (NICM) are unknown. Methods: A retrospective study included subjects with...
6.
Adelstein E, Althouse A, Schwartzman D, Jain S, Soman P, Saba S
Heart Rhythm . 2018 Jun; 15(11):1664-1672. PMID: 29852239
Background: Patients with nonspecific intraventricular conduction delay (IVCD) benefit less from cardiac resynchronization therapy (CRT) than patients with left bundle branch block (LBBB). Objective: The purpose of this study was...
7.
Wang N, Sather M, Hussain A, Althouse A, Adelstein E, Jain S, et al.
Pacing Clin Electrophysiol . 2018 May; 41(7):767-774. PMID: 29761512
Background: Oral anticoagulation (OAC) is prescribed for left atrial thrombi (LAT) in nonrheumatic atrial fibrillation (AF) and/or atrial flutter (AFL). The study objective was to review the existing evidence regarding...
8.
Wang N, Adelstein E, Singh M, Voigt A, Saba S
J Am Coll Cardiol . 2018 Apr; 71(17):1943-1944. PMID: 29699624
No abstract available.
9.
Wang N, Li J, Adelstein E, Althouse A, Sharbaugh M, Jain S, et al.
Pacing Clin Electrophysiol . 2018 Jan; 41(2):143-154. PMID: 29314085
Background: The optimal timing for cardiac resynchronization therapy (CRT) after diagnosis of new-onset left bundle branch block (LBBB)-associated idiopathic nonischemic cardiomyopathy (NICM) and treatment with guideline-directed medical therapy (GDMT) is...
10.
Wang Y, Sharbaugh M, Munir M, Adelstein E, Wang N, Althouse A, et al.
Am J Cardiol . 2017 Oct; 120(12):2201-2206. PMID: 29050686
Cardiac resynchronization therapy (CRT) is an established therapy for heart failure and can be delivered through a CRT pacemaker (CRT-P) or a CRT defibrillator (CRT-D). CRT-P devices are smaller and...